Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)

被引：0
作者：
Hiroki Nakajima
Sadanori Okada
Takako Mohri
Eiichiro Kanda
Naoyuki Inaba
Yoko Hirasawa
Hiroaki Seino
Hisamoto Kuroda
Toru Hiyoshi
Tetsuji Niiya
Hitoshi Ishii
机构：
[1] Nara Medical University,Department of Diabetology
[2] Tokyo Kyosai Hospital,Department of Nephrology
[3] Tokyo Medical and Dental University,Life Science and Bioethics Research Center
[4] Shizuoka Saiseikai General Hospital,Department of Metabolism & Endocrinology
[5] Plumeria DM Clinic,Department of Internal Medicine
[6] Seino Internal Medicine Clinic,undefined
[7] Green Clinic,undefined
[8] Japanese Red Cross Medical Center,undefined
[9] Matsuyama Shimin Hospital,undefined
来源：
Diabetology & Metabolic Syndrome | / 10卷
关键词：
Type 2 diabetes mellitus; Oral hypoglycemic agent; Sodium glucose cotransporters 2 inhibitors; SGLT2 inhibitors; Dapagliflozin; Treatment satisfaction; Oral Hypoglycemic Agent-Questionnaire; Body weight; Patient reported outcome; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 189 条
[61]  
Tamura M(undefined)undefined undefined undefined undefined-undefined
[62]  
Senda M(undefined)undefined undefined undefined undefined-undefined
[63]  
Gunji R(undefined)undefined undefined undefined undefined-undefined
[64]  
Kaku K(undefined)undefined undefined undefined undefined-undefined
[65]  
Terauchi Y(undefined)undefined undefined undefined undefined-undefined
[66]  
Yokote K(undefined)undefined undefined undefined undefined-undefined
[67]  
Nakamura I(undefined)undefined undefined undefined undefined-undefined
[68]  
Sugamori H(undefined)undefined undefined undefined undefined-undefined
[69]  
Xiong W(undefined)undefined undefined undefined undefined-undefined
[70]  
Xiao MY(undefined)undefined undefined undefined undefined-undefined
234567891011